Dermatitis Herpetiformis

Etiopathogenesis & Intro - The Gluten Itch

• Autoimmune, chronic, recurrent blistering disease.
• Characterized by intense pruritus (the "gluten itch").
• Strongly linked to gluten sensitivity and Celiac Disease (CD):
  • Nearly 100% of patients have histological CD.
  • ~75% are symptomatic for CD.
• Pathogenesis: Gluten ingestion triggers IgA antibody production against epidermal transglutaminase (eTG/TG3).
  • Leads to granular IgA deposits at the dermal-epidermal junction.
• Genetic predisposition: HLA-DQ2 (most common) and HLA-DQ8.
  • 📌 Mnemonic: "Dairy Queen: 2 much 8 gluten makes me itch."

⭐ Dermatitis Herpetiformis is considered a cutaneous manifestation of celiac disease; virtually all patients have gluten-sensitive enteropathy.

Clinical Features - Rash on the Double

• Pruritus: Hallmark is intense, paroxysmal itching.
  • Often a burning or stinging sensation.
  • Can precede skin lesions by hours to days.
• Lesions: Typically symmetrical and grouped.
  • Manifest as erythematous papules, vesicles, and urticarial plaques.
  • Bullae are less common and rarely intact due to intense scratching.
  • Excoriations are frequently seen.
• Distribution (📌 SSEKB Mnemonic):
  • Extensor surfaces: Elbows, knees.
  • Buttocks, scalp, posterior nuchal area, shoulders.
  • Scalp, Shoulders, Elbows, Knees, Buttocks.
• Mucosal involvement: Rare.

⭐ The intense pruritus in Dermatitis Herpetiformis is often described as out of proportion to the visible skin lesions.

Diagnosis - Pinpointing the Problem

• Gold Standard: Skin biopsy of perilesional skin for Direct Immunofluorescence (DIF).
  • Shows granular IgA deposits in dermal papillae at the dermo-epidermal junction (DEJ).

  ⭐ Direct Immunofluorescence (DIF) of perilesional skin revealing granular IgA deposits at the dermal-epidermal junction is pathognomonic for Dermatitis Herpetiformis.

• Histopathology (Lesional skin):
  • Subepidermal vesicles/blisters.
  • Neutrophilic microabscesses at tips of dermal papillae.
• Serology:
  • IgA anti-tissue transglutaminase (tTG), IgA anti-endomysial (EMA) antibodies, IgA anti-deamidated gliadin peptide (DGP).
  • Support diagnosis and monitor GFD adherence.
• Celiac Disease Screening:
  • All patients should be evaluated.
  • Duodenal biopsy often shows villous atrophy.

Diagnostic Workflow:

Management & Complications - Diet & Drug Duo

Primary Management:

• Lifelong strict Gluten-Free Diet (GFD):
  • Improves skin & gut symptoms.
  • Reduces medication need.
  • ↓ risk of intestinal lymphoma.

Pharmacological Therapy (Rapid Symptom Control):

• Dapsone:
  • Dose: 50-200 mg/day (titrate to lowest effective dose).
  • Rapid itch relief (24-48h).
  • ⚠️ Screen for G6PD deficiency before starting (risk of hemolysis).
  • Side Effects (SE): 📌 Hemolysis, Agranulocytosis, Methemoglobinemia, Peripheral neuropathy. Monitor CBC.
• Alternatives: Sulfapyridine, sulfasalazine.
• Topical corticosteroids: For symptomatic relief.

Management Algorithm:

Complications:

• Associated celiac disease: Malabsorption, osteoporosis.
• ↑ Risk of non-Hodgkin's lymphoma (especially intestinal if GFD not strictly followed).

⭐ While Dapsone provides rapid symptomatic relief in Dermatitis Herpetiformis, a strict lifelong gluten-free diet is the cornerstone of management and addresses the underlying gut pathology.

High‑Yield Points - ⚡ Biggest Takeaways

• Strong association with celiac disease (gluten-sensitive enteropathy).
• Intensely pruritic papules and vesicles, often grouped (herpetiform).
• Symmetrical distribution on extensor surfaces (elbows, knees, buttocks, scalp).
• Direct Immunofluorescence (DIF): Granular IgA deposits in dermal papillae is pathognomonic.
• Dapsone provides rapid relief of itching and lesions.
• Strict lifelong gluten-free diet is essential for management and prevents complications.
• Histopathology: Subepidermal bullae with neutrophilic abscesses at papillary tips.